191 related articles for article (PubMed ID: 6440477)
1. Postantibiotic effect of imipenem on Pseudomonas aeruginosa.
Bustamante CI; Drusano GL; Tatem BA; Standiford HC
Antimicrob Agents Chemother; 1984 Nov; 26(5):678-82. PubMed ID: 6440477
[TBL] [Abstract][Full Text] [Related]
2. Postantibiotic effect of imipenem, alone and in combination with amikacin, on Pseudomonas aeruginosa.
Gerçeker AA; Otük G
Chemotherapy; 1995; 41(6):433-6. PubMed ID: 8529433
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
Meyer RD; Pasiecznik K
Diagn Microbiol Infect Dis; 1983 Dec; 1(4):287-93. PubMed ID: 6321092
[TBL] [Abstract][Full Text] [Related]
4. [Effect of superinhibitory levels of imipenem and amikacin singly or in combination on Pseudomonas aeruginosa].
Hostacká A
Epidemiol Mikrobiol Imunol; 1997 Dec; 46(4):155-7. PubMed ID: 9471306
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro interactions of ceftazidime, meropenem, and imipenem with amikacin on multiresistant Pseudomonas aeruginosa.
Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H
Diagn Microbiol Infect Dis; 1997 Oct; 29(2):81-6. PubMed ID: 9368083
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
Tessier F; Quentin C
Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
[TBL] [Abstract][Full Text] [Related]
7. N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics.
Martino P; Venditti M; Valente B; Brandimarte C; Serra P
Drugs Exp Clin Res; 1985; 11(4):247-51. PubMed ID: 3939121
[TBL] [Abstract][Full Text] [Related]
8. Study of in vitro selected resistance of Pseudomonas aeruginosa to cefoperazone, ceftazidime, azthreonam and imipenem.
Van der Auwera P; Husson M; Bulliard G
Drugs Exp Clin Res; 1986; 12(11):871-83. PubMed ID: 3102194
[TBL] [Abstract][Full Text] [Related]
9. The morphological response of Pseudomonas aeruginosa to azthreonam, cefoperazone, ceftazidime and N-formimidoyl thienamycin.
Elliott TS; Greenwood D
J Med Microbiol; 1984 Apr; 17(2):159-69. PubMed ID: 6423826
[TBL] [Abstract][Full Text] [Related]
10. Serum bactericidal activity and killing rate for volunteers receiving imipenem, imipenem plus amikacin, and ceftazidime plus amikacin against Pseudomonas aeruginosa.
Van der Auwera P; Klastersky J; Lagast H; Husson M
Antimicrob Agents Chemother; 1986 Jul; 30(1):122-6. PubMed ID: 3092729
[TBL] [Abstract][Full Text] [Related]
11. Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin.
Chau PY; Ling J; Ng WS
J Antimicrob Chemother; 1983 Oct; 12(4):337-45. PubMed ID: 6417100
[TBL] [Abstract][Full Text] [Related]
12. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated at Kochi Municipal Central Hospital in the last 3 years].
Nasu Y; Abe M; Ono N; Araki M; Horimi T; Takahashi I
Jpn J Antibiot; 2004 Oct; 57(5):438-48. PubMed ID: 15655905
[TBL] [Abstract][Full Text] [Related]
13. [Antibiotic susceptibility and occurrence of ESBL in Pseudomonas aeruginosa strains isolated from different clinical specimens].
Sacha PT; Jakoniuk P; Wieczorek P; Zalewska M; Leszczyńska K
Med Dosw Mikrobiol; 2004; 56(3):263-73. PubMed ID: 15773503
[TBL] [Abstract][Full Text] [Related]
14. [Comparative bactericidal activity of imipenem and other antibiotics against Pseudomonas aeruginosa].
Thabaut A; Meyran M
Pathol Biol (Paris); 1988 May; 36(5):472-6. PubMed ID: 3136428
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.
Cullmann W; Opferkuch W; Stieglitz M; Werkmeister U
Antimicrob Agents Chemother; 1982 Aug; 22(2):302-7. PubMed ID: 6821459
[TBL] [Abstract][Full Text] [Related]
16. In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo-beta-lactamase-producing Pseudomonas aeruginosa.
Oie S; Fukui Y; Yamamoto M; Masuda Y; Kamiya A
BMC Infect Dis; 2009 Aug; 9():123. PubMed ID: 19664245
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ceftazidime and N-formimidoyl thienamycin against gentamicin-susceptible and resistant Pseudomonas aeruginosa.
Alford RH
J Antimicrob Chemother; 1983 Jun; 11(6):599-601. PubMed ID: 6411675
[No Abstract] [Full Text] [Related]
18. [Antibacterial effect of N-formimidoyl-thienamycin in combination with amikacin, cefoxitin and fosfomycin on K. pneumoniae and P. aeruginosa].
Schröter G; Schrettenbrunner A
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Dec; 253(3):355-7. PubMed ID: 6820589
[No Abstract] [Full Text] [Related]
19. High β-lactamase levels change the pharmacodynamics of β-lactam antibiotics in Pseudomonas aeruginosa biofilms.
Hengzhuang W; Ciofu O; Yang L; Wu H; Song Z; Oliver A; Høiby N
Antimicrob Agents Chemother; 2013 Jan; 57(1):196-204. PubMed ID: 23089750
[TBL] [Abstract][Full Text] [Related]
20. Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa.
Stratton CW; Weeks LS; Tausk F
J Antimicrob Chemother; 1987 Jan; 19(1):21-5. PubMed ID: 3104276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
